ANALYSIS OF MEDICATION ADHERENCE AMONG PATIENTS TAKING DIRECT-ACTING ANTIVIRAL S FOR THE TREATMENT OF CHRONIC HEPATITIS C

被引：0
|
作者：
Margusino-Framinan, L. [1 ]
Castro-Iglesias, A. [1 ]
Mena-de-Cea, A. [1 ]
Cid-Silva, P. [1 ]
Pernas-Souto, B. [1 ]
Rodriguez-Osorio, I [1 ]
Vazquez-Rodriguez, P. [1 ]
Lopez-Calvo, S. [1 ]
Sanclaudio-Luhia, I [1 ]
Castro-Castro, J. A. [1 ]
Martin-Herranz, I [1 ]
机构：
[1] A Coruna Hosp, La Coruna, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1100
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN54
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [41] Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients
    Cooper, Curtis L.
    Hatashita, Holly
    Corsi, Daniel J.
    Parmar, Parmvir
    Corrin, Raymond
    Garber, Gary
    ANNALS OF HEPATOLOGY, 2017, 16 (06) : 874 - 880
  • [42] Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C
    Gellad, Ziad F.
    Reed, Shelby D.
    Muir, Andrew J.
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1189 - 1199
  • [43] Management of Direct-Acting Antiviral Failures in Chronic Hepatitis C Infection
    Kevin Tin
    Eiei Soe
    James Park
    Current Hepatology Reports, 2016, 15 (4) : 296 - 306
  • [44] Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C
    Turcu-Stiolica, Adina
    Doica, Irina Paula
    Ungureanu, Bogdan Silviu
    Rogoveanu, Ion
    Florescu, Dan Nicolae
    Subtirelu, Mihaela-Simona
    Gheonea, Dan Ionut
    PHARMACEUTICS, 2021, 13 (10)
  • [45] Reactivation of Hepatitis B Virus in Chronic Hepatitis B and C Coinfected Patients Treated with Direct-Acting Antiviral Treatment
    Chen, Chien Hung
    Jeng, Wen-Juei
    Lin, Chun-Yen
    Hu, Tsung-Hui
    Chien, Rong-Nan
    Sheen, I-Shyan
    HEPATOLOGY, 2018, 68 : 390A - 390A
  • [46] Treatment of Hepatitis C in Patients with Cirrhosis: Remaining Challenges for Direct-Acting Antiviral Therapy
    Avik Majumdar
    Matthew T. Kitson
    Stuart K. Roberts
    Drugs, 2015, 75 : 823 - 834
  • [47] Fibrosis Regression Post Direct-acting Antiviral Treatment in Hepatitis C Virus Patients
    Demir, Nurhan
    Gulluoglu, Alper
    MEDICAL JOURNAL OF BAKIRKOY, 2023, 19 (01) : 15 - 21
  • [48] Favorable outcome with direct-acting antiviral treatment in hepatitis C patients coinfected with HIV
    Ishida, Hisashi
    Ishihara, Akio
    Tanaka, Satoshi
    Iwasaki, Tetsuya
    Hasegawa, Hiroko
    Akasaka, Tomofumi
    Sakakibara, Yuko
    Nakazuru, Shoichi
    Uehira, Tomoko
    Shirasaka, Takuma
    Mita, Eiji
    HEPATOLOGY RESEARCH, 2019, 49 (09) : 1076 - 1082
  • [49] Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital
    Hawsawi, Nahed Mohammed
    Saber, Tamer
    Salama, Hussein M.
    Fouad, Walaa S.
    Hagag, Howaida M.
    Alhuthali, Hayaa M.
    Eed, Emad M.
    Saber, Taisir
    Ismail, Khadiga A.
    Al Qurashi, Hesham H.
    Altowairqi, Samir
    Samaha, Mohmmad
    El-Hossary, Dalia
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (02)
  • [50] Measuring Adherence to Hepatitis C Direct-Acting Antiviral Medications: Using the VAS in an HCV Treatment Clinic
    Burton, Mary Jane
    Voluse, Andrew C.
    Patel, Amee B.
    Konkle-Parker, Deborah
    SOUTHERN MEDICAL JOURNAL, 2018, 111 (01) : 45 - 50
12345